Trial Profile
A randomized, double-blind, single-dose, placebo-controlled, multicenter study of gabapentin 100 mg and 250 mg in transient insomnia induced by a sleep phase advance
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 04 Feb 2021
Price :
$35
*
At a glance
- Drugs Gabapentin (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- Sponsors Pfizer
- 14 May 2008 New trial record.